Co-delivery of IL-2 or liposomes augment the responses of mice to a DNA vaccine for pseudorabies virus IE180

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 26, Issue 3, 2003, Pages 175-187

  Bu, J ^a   Song, Y ^a   Rompato, G ^a   Burgess, D J ^a   Garmendia, A E ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

DNA vaccine; IL 2; Liposomes; Pseudorabies virus

Indexed keywords

ANTIBODY; DNA VACCINE; IMMEDIATE EARLY PROTEIN; INTERLEUKIN 2; LIPOSOME; NAKED DNA; PSEUDORABIES VACCINE;

ANIMAL TISSUE; ANTIBODY RESPONSE; COMPLEX FORMATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DESIGN; FEMALE; GENE GUN; IMMUNOGENICITY; MOUSE; MOUSE STRAIN; NONHUMAN; PLASMID; PSEUDORABIES HERPETOVIRUS; REVIEW; SEROCONVERSION; SINGLE DRUG DOSE; SURVIVAL RATE; TIME OF DEATH; VIRUS STRAIN;

SUID HERPESVIRUS 1;

EID: 0344837288     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9571(02)00050-4     Document Type: Article

References (37)

1. Ulmer JB, Donnelly JJ, Parker SE, Rhndca GH, Felgner PI, Dwarki VJ, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259: 1745-9.
2. McClements WL, Armstrong ME, Keys RD, Liu MA. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc Natl Acad Sci USA 1996; 93:11414-20.
3. Gonzalez AJC, Morello CS, Granmer LD, Spector DH. DNA immunization confers protein against murine cytomegalovirus infection. J Virol 1996;70:7921-8.
4. Michel ML, Davis HL, Schleef M, Mancini M, Tiollais P, Whalen RG. DNA-based immunization to the hepatitis B surface antigen in mice: aspect of humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 1993;92:5307-11.
5. Rhodes GH, Abai AM, Margalith M, Kuwahara RA, Morrow J, Parker SE, et al. Characterization of humoral immunity after DNA injection. Dev Biol Stand 1994;82: 229-36.
6. Osterrieder N, Wagner R, Brandmuller C, Schmidt P, Wolf H, Kaaden OR. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14. Virology 1994;208:500-10.
7. Yokoyama M, Zhang J, Whitton JL. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J Virol 1995;69:2684-8.
8. Martins LP, Lau LL, Asano MS, Ahmed R. DNA vaccination against persistent viral infection. J Virol 1995;69:2574-82.
9. Chang SW, Bu J, Rompato G, Garmendia AE. A vector DNA vaccine encoding pseudorabies virus immediate early protein demonstrates partial protection in mice against lethal virus challenge. Viral Immunol 1998;11:27-36.
10. Ihara S, Feldman L, Wantanabe S, Ben-Porat T. Characterization of the immediate-early functions of pseudorabies virus. Virology 1983;131:437-54.
11. Manickan ER, Rouse JD, Yu Z, Wire WS, Rouse BT. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP27. Viral Immunol 1995;8:53-61.
12. Chow Y, Huang W, Chi W, Chu Y, Tao M. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 1997;71:169-78.
13. Davis HL, Whalen RG, Demeneix BA. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum Gene Ther 1993;4:151-9.
14. Wolff JA, Williams P, Acsadi G, Jiao S, Jani G, Chong W. Conditions affecting direct gene transfer into skeletal muscle into rodent mouse in vivo. Biotechniques 1991;11:474-85.
15. Gregoriadis G, Saffie R, de Souza JB. Liposome-mediated DNA vaccination. FEBS Lett 1997; 402:107-10.
16. Ishii N, Fukushima J, Kaneko T, Okada E, Tani K, Tanaka SI, et al. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1997;13:1421-8.
17. Liu Y, Liggia D, Zhong W, Tu G, Gaensler K, Debs R. Cationic liposome-mediated intravenous gene delivery. J Biol Chem 1995;270:24864-70.
18. Gregoriadis G, Saffie R, Hart SL. High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection efficiency. J Drug Target 1996;3:467-75.
19. Velinova M, Read N, Kirby C, Gregoriadis G. Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats. Biochim Biophys Acta 1996;1299:207-15.
20. Fu TM, Ulmer JB, Caulfield MJ, Deck RR, Friedman A, Wang S, et al. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med 1997;3:362-71.
21. Yokoyama M, Zhang J, Whitton JL. DNA immunization: effect of vehicle and route of administration on the induction of protective antiviral immunity. FEMS Immunol Med Microbiol 1996;14:221-30.
22. Klavinskis LS, Gao L, Barnfield C, Lehner T, Parker S. Mucosal immunization with DNA-liposome complex. Vaccine 1997;15:818-20.
23. Okada E, Sasaki S, Ishii N, Aoki I, Yasuda T, Nishiioka K, et al. Intranasal immunization of a DNA vaccine with IL-12 and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induce strong mucosal and cell mediated immune response against HIV-1 antigen. J Immunol 1997;159:3638-47.
24. Chow Y, Chiang B, Lee Y, Chi E, Lin W, Chen Y, et al. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol 1998;160:1320-9.
25. Nunberg JH, Doyel MV, York SM, York CJ. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proc Natl Acad Sci USA 1989;86:4240-3.
26. Weinberg A, Merigan TC. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines. J Immunol 1988;140:249-99.
27. Farrar WL, Johnson HM, Farrar JJ. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukine-2. J Immunol 1981;126:1120-5.
28. Kawase I, Brooks CG, Kuribayashi K, Olabuenaga S, Newman W, Gills S, et al. Interleukine-2 induces gamma-interferon production: participation of macrophages and NK-like cells. J Immunol 1983;131:288-92.
29. Weyand CM, Goronzy J, Dallman MJ, Fathman CG. Interleukine-2 in vivo also induces a polyclonal IgM response. J Exp Med 1986;163:1607-12.
30. Sin J, Kim JJ, Boyer JD, Ciccarelli RB, Higgins TJ, Weiner DB. In vivo modulation of vaccine-induced immnue responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model. J Virol 1999;73:501-9.
31. Larsen DL, Sissoko ND, McGregor MW, Drape R, Neumann V, Swain WF, et al. Coadministration of DNA encoding interleukine-6 and hemagglutinin confers protection from influenza virus challenge in mice. J Virol 1997;72:1704-8.
32. Hong K, Zheng W, Baker A, Papahadjopoulos D. Stabilization of cationic liposome-plasmid DNA complex by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett 1996;400:223-33.
33. Sternberg B, Hong K, Zheng W, Papahadjopoulos D. Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo. Biochim Biophys Acta 1998;1375:23-5.
34. Mahato RI, Rolland A, Tomlinson E. Cationic lipid-based gene delivery systems: pharmaceutical perspectives. Pharm Res 1997;14:853-9.
35. Tarahovsky YS, Ivanitsky GR. Liposomes in gene therapy. Structural polymorphism of lipids and effectiveness of gene delivery. Biochemistry 1998;63:607-18.
36. Campbell MJ. Lipofection reagents prepared by a simple ethanol injection technique. Biotechniques 1995;18:1027-32.
37. Rose JK, Buonocore L, Whitt MA. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques 1991;10:3520-5.